Access to Medicines and the Global Fund
The affordability, availability, and financing of medicines and other health commodities has always been a central issue for the Global Fund to Fight AIDS, Tuberculosis, and Malaria, its donors, recipient countries, and affected communities. Given the significant amount and proportion of Global Fund grant funding that goes to health commodities procurement, the strategic and operational components of their procurement and price strategies, and the availability of suppliers and access to their products, are key to ensuring availability and affordability of medicines.
Current and proposed policies have created a growing concern that the Global Fund is fundamentally altering its approach to access to medicines. There appears to be a progressive rollback of its previous position of the promotion of generic competition as a key driver for lowering costs to a more opaque, centralized, collaborative approach with both generic producers and originators that risks reducing individual country ownership and threatening the continued supply of low-cost generic production. In addition, given the increasingly global spread of patenting, it is critical to also explore additional ways to challenge (and overcome) the high prices of new medicines.
In light of these concerns, advocates should explore whether and how to expand and connect activities in relation to the Global Fund and access to medicines issues more broadly. To help promote that debate, this paper provides a preliminary identification of five areas that illustrate these concerns, and where the Global Fund’s present or future policies could either enhance or limit the potential to use generic competition, rights-based advocacy, and/or its public purchasing power to lower the price of medicines.
Access to Medicines and the Global Fund (2.28 Mb pdf file)
Download the 14-page briefing paper.
Q&A: Africa’s Fight for Vaccine Equity
As the pandemic enters its third year, African Alliance founder Tian Johnson shares reflections on how to make progress in the push for vaccine equity and what African civil society organizations are asking for now.
Dignified End-of-Life Care
Governments Should Follow Moldova’s Lead and Ensure Universal Access to Palliative Care
Over decades, Open Society’s funding for palliative care has improved access globally. However, while philanthropy plays a large role in this sector, palliative care must ultimately be publicly funded and universally available.
A Holistic Answer
Demanding a Just COVID-19 Response
As our grantees, partners, and allies work tirelessly to reduce the damage brought on by the pandemic, we at Open Society are committed to long-term reforms that will address the structural injustices worsened by the virus.